Developer docs
API playgroundTry for free, no card

Search company profiles

PharmaForceIQ

Full company profile

uuid003w52h

Namestring
PharmaForceIQ
Legal namestring
PharmaForceIQ
Company typeenum
Private
Founded yearint
2020
Descriptiontext

PharmaForceIQ is a US-based, private enterprise SaaS company founded in 2020 that provides an AI-powered optichannel customer engagement platform for pharmaceutical and biotech commercial teams. The platform unifies brand and field strategy through a combination of proprietary affinity data on 7M+ healthcare professionals (HCPs), AI-driven Next-Best-Action (NBA) recommendations, and real-time orchestration across field, digital, and peer-to-peer channels. Content is deployed within 24-48 hours of clinical or behavioral signal detection across 75,000+ digital sites and platforms, with native integrations into Veeva CRM, Medscape NBE, EHR data, and medical/script claims vendors.

Following the January 2026 asset acquisition of Aktana, PharmaForceIQ combined its digital orchestration platform with Aktana's AI-driven field NBA capabilities, creating an end-to-end optichannel-in-a-box solution. The integrated stack incorporates Aktana's Knowledge Nexus dataset (built on 100M+ field suggestions and 5,000+ tactics executed over twelve years) and the TacticGenie AI journey planner. The company serves pharmaceutical and biotech clients across oncology, rare disease, and other therapeutic areas, with named or referenced customers including Day One Biopharmaceuticals, Merck (Medical Affairs), and Merus, plus multiple anonymized large-pharma enterprise engagements.

PharmaForceIQ operates on a flat-fee enterprise subscription model that bundles technology, data, and media contracting, distinguishing it from traditional agency commission structures. The company received a majority investment from healthcare-focused PE firm Eir Partners in September 2024 and has subsequently expanded its geographic footprint across the United States, LATAM, APAC, and EMEA. The company holds ISO 27001, SOC 2 Type II, HIPAA, HITECH, CCPA, and NAI certifications, supporting its position with regulated pharma buyers and creating procurement-grade compliance baselines.

Short descriptiontext

PharmaForceIQ is an AI-powered optichannel customer engagement platform for pharmaceutical and biotech companies, unifying brand and field strategy through real-time HCP affinity data, AI-driven Next-Best-Action recommendations, and deployment across 75,000+ digital and field channels.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersMiami, United States
HQ citystring
Miami
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharmaceutical marketing software, HCP engagement platform, optichannel orchestration, field next-best-action, pharma commercial AI
Industry1 code
PRIMARYHDAEANAC
Model Serving, Inference & Deployment Platforms (APIs, Edge/On-Prem)
Hardware, Technology & Telecom/Enterprise Platforms & Databases/Artificial Intelligence Platforms for Enterprise
NAICS code1 code
  • Software Publishers5132
SIC code1 code
  • Services-Prepackaged Software7372
Product category
Pharmaceutical Marketing Software
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Platform Subscription and Licensing
TypeSubscription Recurring
Description

Enterprise SaaS platform providing end-to-end customer engagement capabilities. The company charges a flat fee that includes technology, data, and media contracting. The model incentivizes efficiency rather than higher spend, differentiating from traditional agency commission models that incentivize higher budgets.

pharmaforceiq.com
2Professional Services and Implementation
TypeProfessional Services
Description

Strategic partnership and implementation services to deploy the optichannel-in-a-box solution. Deployable in 6-8 weeks.

pharmaforceiq.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Marketing or Sales, Infrastructure, Operations
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

PharmaForceIQ sells an AI-powered "optichannel-in-a-box" customer engagement platform for pharmaceutical and biotech companies that unifies brand and field strategy in real time. The platform deploys personalized content across field, digital, and peer-to-peer channels based on clinical and behavioral signals, with deployment speeds of 24-48 hours and reach across 75,000+ digital sites plus a proprietary database of 7M+ HCP profiles. Following the January 2026 acquisition of Aktana, the offering now also bundles AI-driven field Next-Best-Action recommendations powered by Aktana's Knowledge Nexus dataset.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 11 values shown
  • 3x average script lift
+10 more records
Product overview1 text field

PharmaForceIQ offers a unified optichannel customer engagement platform for life sciences, combining a core orchestration platform with modular AI-powered components. The platform integrates the company's proprietary Affinity Intelligence (7M+ HCP profiles), Real-Time Analytics Dashboard, and deployment across 75,000+ digital channels with Aktana's Field Next-Best-Action capabilities (including Knowledge Nexus dataset and TacticGenie AI journey planner) to deliver the industry's first end-to-end 'optichannel-in-a-box' solution. The integrated system unifies brand and field strategy, powers Next-Best-Action recommendations for sales reps, and deploys personalized content within 24 hours of clinical triggers. PharmaForceIQ offers specialized solutions for Commercial Leaders, HCP Marketers, DTC Marketers, Omnichannel Leaders, Medical Affairs, and Sales Leadership teams.

Product and service2 records
1PharmaForceIQ Optichannel Platform
CategoryCustomer Engagement Platform
Description

An end-to-end real-time customer engagement platform that unifies brand and field strategy for pharmaceutical commercial teams, using AI-powered optichannel marketing to engage healthcare professionals and patients across optimal channels with personalized content deployed within 24 hours of triggers.

2Aktana Field Next-Best-Action Platform
CategoryField Sales Orchestration
Description

AI-driven field orchestration platform providing Next-Best-Action recommendations to pharmaceutical sales reps, powered by Aktana's proprietary Knowledge Nexus dataset built on over 100 million field suggestions and 5,000+ tactics executed over twelve years. Now integrated into the PharmaForceIQ platform.

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-01-07
Description

PharmaForceIQ acquired Aktana in an asset purchase combining its digital orchestration platform with Aktana's AI-driven field Next-Best-Action capabilities. This creates the industry's first 'optichannel-in-a-box' commercial engagement system. Aktana's Knowledge Nexus dataset contains insights from 100M+ field suggestions and 5,000+ tactics over twelve years. Derek Choy, former Co-Founder and CPO of Aktana, joined as PharmaForceIQ's Head of Product.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Medscape's Next Best Engagement (NBE) program is one of the high-performing channels in PharmaForceIQ's platform. Medscape accounted for approximately 45% of all engagements in the first 12 months of one campaign and was identified as the highest performing platform among third-party partners.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Ogilvy Health (WPP Health Practice) is a global pharma/health creative and engagement agency. While primarily services-led rather than platform-led, it competes for the same commercial-leader budget that PFIQ targets with its optichannel-in-a-box proposition.

TypeDirect peer
Description

OptimizeRx operates a point-of-care/HCP engagement platform that reaches prescribers through EHR workflows and delivers real-time messaging during clinical decision moments. It directly competes with PFIQ in the HCP-trigger-based, signal-driven engagement category, especially for non-personal promotion.

TypeDirect peer
Description

Veeva is the dominant enterprise SaaS platform for pharma commercial operations, including Veeva CRM (field sales) and PromoMats. PFIQ integrates with Veeva CRM to deploy NBA suggestions into rep workflows, making Veeva a direct competitor on field orchestration and the most relevant benchmark for pharma commercial SaaS.

TypeDirect peer
Description

Real Chemistry (formerly W2O Group) is an AI-driven healthcare marketing agency with integrated health intelligence data, audience targeting, and content orchestration. They compete for the same commercial-leader budget that PFIQ targets, with comparable client rosters among top-20 pharma.

TypeDirect peer
Description

DeepIntent is a programmatic advertising platform purpose-built for pharma, with HCP and DTC activation, identity resolution, and measurement. It competes for the same digital pharma media and engagement budget that PFIQ's Orchestration Engine executes against.

6ZS Associates
TypeDirect peer
Description

ZS runs the Affinity portfolio (AffinityMonitor, AffinityMap, AffinityLive, AffinityEngage) providing pharma HCP audience intelligence and field/digital orchestration. ZS is the most direct functional analog to PFIQ's Affinity Intelligence + orchestration stack, serving the same pharma commercial buyers.

TypeDirect peer
Description

Indegene is a digital-first commercial services and technology provider for life sciences, offering omnichannel HCP/patient engagement, medical affairs, and content platforms. It competes directly with PFIQ for marketing-tech and omnichannel budgets inside pharma and biotech.

TypeBroad incumbent
Description

IQVIA offers Orchestrated Customer Engagement (OCE) and a broad portfolio of pharma commercial analytics, RWD, and sales force effectiveness tools. It is a broader incumbent serving many of the same pharma commercial leaders PFIQ targets, but as part of a vast life-sciences services platform.

TypeDirect peer
Description

Intouch Group is a pharma-focused digital marketing agency with proprietary AI and analytics offerings (e.g., AI Media Planning), directly serving HCP and DTC marketing needs PFIQ's solutions address.

TypeBroad incumbent
Description

EVERSANA is a large pharma commercialization services provider (sales, marketing, data, distribution) that increasingly offers AI-enabled engagement technology. It is an incumbent that competes broadly across pharma commercial workflows PFIQ addresses.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers8 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment6 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration5 records

Each record includes

Title, Type, Description, Source

AI capability9 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance6 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

PharmaForceIQ

Pharmaceutical Marketing Softwarepharmaforceiq.com

PharmaForceIQ is an AI-powered optichannel customer engagement platform for pharmaceutical and biotech companies, unifying brand and field strategy through real-time HCP affinity data, AI-driven Next-Best-Action recommendations, and deployment across 75,000+ digital and field channels.

What PharmaForceIQ does

PharmaForceIQ is a US-based, private enterprise SaaS company founded in 2020 that provides an AI-powered optichannel customer engagement platform for pharmaceutical and biotech commercial teams. The platform unifies brand and field strategy through a combination of proprietary affinity data on 7M+ healthcare professionals (HCPs), AI-driven Next-Best-Action (NBA) recommendations, and real-time orchestration across field, digital, and peer-to-peer channels. Content is deployed within 24-48 hours of clinical or behavioral signal detection across 75,000+ digital sites and platforms, with native integrations into Veeva CRM, Medscape NBE, EHR data, and medical/script claims vendors.

Following the January 2026 asset acquisition of Aktana, PharmaForceIQ combined its digital orchestration platform with Aktana's AI-driven field NBA capabilities, creating an end-to-end optichannel-in-a-box solution. The integrated stack incorporates Aktana's Knowledge Nexus dataset (built on 100M+ field suggestions and 5,000+ tactics executed over twelve years) and the TacticGenie AI journey planner. The company serves pharmaceutical and biotech clients across oncology, rare disease, and other therapeutic areas, with named or referenced customers including Day One Biopharmaceuticals, Merck (Medical Affairs), and Merus, plus multiple anonymized large-pharma enterprise engagements.

PharmaForceIQ operates on a flat-fee enterprise subscription model that bundles technology, data, and media contracting, distinguishing it from traditional agency commission structures. The company received a majority investment from healthcare-focused PE firm Eir Partners in September 2024 and has subsequently expanded its geographic footprint across the United States, LATAM, APAC, and EMEA. The company holds ISO 27001, SOC 2 Type II, HIPAA, HITECH, CCPA, and NAI certifications, supporting its position with regulated pharma buyers and creating procurement-grade compliance baselines.

PharmaForceIQ firmographics

Firmographics
Name
PharmaForceIQ
Legal name
PharmaForceIQ
Website
https://pharmaforceiq.com
Company type
Private
Founded year
2020
Operating status
Operating
Headcount range
101–250 employees
Short description
PharmaForceIQ is an AI-powered optichannel customer engagement platform for pharmaceutical and biotech companies, unifying brand and field strategy through real-time HCP affinity data, AI-driven Next-Best-Action recommendations, and deployment across 75,000+ digital and field channels.
Ownership category
akta.pro rank

PharmaForceIQ industry classification

Industry
Product category
Pharmaceutical Marketing Software
NAICS
Software Publishers (5132)
SIC
Services-Prepackaged Software (7372)
akta.pro industry
PRIMARYHDAEANAC
Model Serving, Inference & Deployment Platforms (APIs, Edge/On-Prem)
Hardware, Technology & Telecom/Enterprise Platforms & Databases/Artificial Intelligence Platforms for Enterprise

Keywords

  • Pharmaceutical marketing software
  • HCP engagement platform
  • Optichannel orchestration
  • Field next-best-action
  • Pharma commercial AI

Where PharmaForceIQ is headquartered

Location

Headquarters

HQ city
Miami
HQ country
United States
HQ region
North America

Offices2 records

Markets served

PharmaForceIQ business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Infrastructure, Operations

Revenue model

  1. Platform Subscription and Licensing: Enterprise SaaS platform providing end-to-end customer engagement capabilities. The company charges a flat fee that includes technology, data, and media contracting. The model incentivizes efficiency rather than higher spend, differentiating from traditional agency commission models that incentivize higher budgets.
  2. Professional Services and Implementation: Strategic partnership and implementation services to deploy the optichannel-in-a-box solution. Deployable in 6-8 weeks.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

PharmaForceIQ product offering

Product offering

Core offering

PharmaForceIQ sells an AI-powered "optichannel-in-a-box" customer engagement platform for pharmaceutical and biotech companies that unifies brand and field strategy in real time. The platform deploys personalized content across field, digital, and peer-to-peer channels based on clinical and behavioral signals, with deployment speeds of 24-48 hours and reach across 75,000+ digital sites plus a proprietary database of 7M+ HCP profiles. Following the January 2026 acquisition of Aktana, the offering now also bundles AI-driven field Next-Best-Action recommendations powered by Aktana's Knowledge Nexus dataset.

Product overview

PharmaForceIQ offers a unified optichannel customer engagement platform for life sciences, combining a core orchestration platform with modular AI-powered components. The platform integrates the company's proprietary Affinity Intelligence (7M+ HCP profiles), Real-Time Analytics Dashboard, and deployment across 75,000+ digital channels with Aktana's Field Next-Best-Action capabilities (including Knowledge Nexus dataset and TacticGenie AI journey planner) to deliver the industry's first end-to-end 'optichannel-in-a-box' solution. The integrated system unifies brand and field strategy, powers Next-Best-Action recommendations for sales reps, and deploys personalized content within 24 hours of clinical triggers. PharmaForceIQ offers specialized solutions for Commercial Leaders, HCP Marketers, DTC Marketers, Omnichannel Leaders, Medical Affairs, and Sales Leadership teams.

Differentiator

Problem solved

Functional benefit

Products and services

  • PharmaForceIQ Optichannel Platform An end-to-end real-time customer engagement platform that unifies brand and field strategy for pharmaceutical commercial teams, using AI-powered optichannel marketing to engage healthcare professionals and patients across optimal channels with personalized content deployed within 24 hours of triggers.
  • Aktana Field Next-Best-Action Platform AI-driven field orchestration platform providing Next-Best-Action recommendations to pharmaceutical sales reps, powered by Aktana's proprietary Knowledge Nexus dataset built on over 100 million field suggestions and 5,000+ tactics executed over twelve years. Now integrated into the PharmaForceIQ platform.

Quantifiable outcome

  • 3x average script lift
  • +10 more outcomes

Companies that use PharmaForceIQ

Customer profile

Named customers8 records

Segments6 records

Ideal customer profiles3 records

PharmaForceIQ technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration5 records

AI capability9 records

Feature5 records

PharmaForceIQ partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core and minor.

  • AktanacoreStrategic or Co-development Partner · 7 January 2026PharmaForceIQ acquired Aktana in an asset purchase combining its digital orchestration platform with Aktana's AI-driven field Next-Best-Action capabilities. This creates the industry's first 'optichannel-in-a-box' commercial engagement system. Aktana's Knowledge Nexus dataset contains insights from 100M+ field suggestions and 5,000+ tactics over twelve years. Derek Choy, former Co-Founder and CPO of Aktana, joined as PharmaForceIQ's Head of Product.
  • MedscapeminorChannel Partner/ Reseller/ DistributorMedscape's Next Best Engagement (NBE) program is one of the high-performing channels in PharmaForceIQ's platform. Medscape accounted for approximately 45% of all engagements in the first 12 months of one campaign and was identified as the highest performing platform among third-party partners.

Scale indicators7 records

Recent moves6 records

Expansion highlights6 records

PharmaForceIQ competitors and assessment

Company assessment

Broad incumbents

  • Ogilvy Health: Ogilvy Health (WPP Health Practice) is a global pharma/health creative and engagement agency. While primarily services-led rather than platform-led, it competes for the same commercial-leader budget that PFIQ targets with its optichannel-in-a-box proposition.
  • IQVIA: IQVIA offers Orchestrated Customer Engagement (OCE) and a broad portfolio of pharma commercial analytics, RWD, and sales force effectiveness tools. It is a broader incumbent serving many of the same pharma commercial leaders PFIQ targets, but as part of a vast life-sciences services platform.
  • EVERSANA: EVERSANA is a large pharma commercialization services provider (sales, marketing, data, distribution) that increasingly offers AI-enabled engagement technology. It is an incumbent that competes broadly across pharma commercial workflows PFIQ addresses.

Direct peers

  • OptimizeRx: OptimizeRx operates a point-of-care/HCP engagement platform that reaches prescribers through EHR workflows and delivers real-time messaging during clinical decision moments. It directly competes with PFIQ in the HCP-trigger-based, signal-driven engagement category, especially for non-personal promotion.
  • Veeva Systems: Veeva is the dominant enterprise SaaS platform for pharma commercial operations, including Veeva CRM (field sales) and PromoMats. PFIQ integrates with Veeva CRM to deploy NBA suggestions into rep workflows, making Veeva a direct competitor on field orchestration and the most relevant benchmark for pharma commercial SaaS.
  • Real Chemistry: Real Chemistry (formerly W2O Group) is an AI-driven healthcare marketing agency with integrated health intelligence data, audience targeting, and content orchestration. They compete for the same commercial-leader budget that PFIQ targets, with comparable client rosters among top-20 pharma.
  • DeepIntent: DeepIntent is a programmatic advertising platform purpose-built for pharma, with HCP and DTC activation, identity resolution, and measurement. It competes for the same digital pharma media and engagement budget that PFIQ's Orchestration Engine executes against.
  • ZS Associates: ZS runs the Affinity portfolio (AffinityMonitor, AffinityMap, AffinityLive, AffinityEngage) providing pharma HCP audience intelligence and field/digital orchestration. ZS is the most direct functional analog to PFIQ's Affinity Intelligence + orchestration stack, serving the same pharma commercial buyers.
  • Indegene: Indegene is a digital-first commercial services and technology provider for life sciences, offering omnichannel HCP/patient engagement, medical affairs, and content platforms. It competes directly with PFIQ for marketing-tech and omnichannel budgets inside pharma and biotech.
  • Intouch Group / VMLY&R Health: Intouch Group is a pharma-focused digital marketing agency with proprietary AI and analytics offerings (e.g., AI Media Planning), directly serving HCP and DTC marketing needs PFIQ's solutions address.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat6 records

Key risks5 records

Key highlights6 records

Customer concentration

PharmaForceIQ social profiles

Digital presence

PharmaForceIQ compliance and trust

Trust signal

Compliance6 records

PharmaForceIQ financial estimates

Financial estimate

Revenue estimate

Valuation estimate

PharmaForceIQ leadership team

Management profile

Number of profiles

Profiles5 records

PharmaForceIQ subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

PharmaForceIQ funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

PharmaForceIQ M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about PharmaForceIQ

What does PharmaForceIQ do?

PharmaForceIQ sells an AI-powered "optichannel-in-a-box" customer engagement platform for pharmaceutical and biotech companies that unifies brand and field strategy in real time. The platform deploys personalized content across field, digital, and peer-to-peer channels based on clinical and behavioral signals, with deployment speeds of 24-48 hours and reach across 75,000+ digital sites plus a proprietary database of 7M+ HCP profiles. Following the January 2026 acquisition of Aktana, the offering now also bundles AI-driven field Next-Best-Action recommendations powered by Aktana's Knowledge Nexus dataset.

Is PharmaForceIQ a public or private company?

PharmaForceIQ is a private company. It is classified as private equity controlled and is currently operating.

When was PharmaForceIQ founded?

PharmaForceIQ was founded in 2020. It employs 101 to 250 people.

Where is PharmaForceIQ based?

PharmaForceIQ is headquartered in Miami, United States, in the North America region.

How does PharmaForceIQ make money?

Two revenue lines are on record. Platform Subscription and Licensing is the primary driver. The others are professional Services and Implementation.

Who are PharmaForceIQ's main competitors?

Broad incumbents on record are Ogilvy Health, IQVIA and EVERSANA. Direct peers are OptimizeRx, Veeva Systems, Real Chemistry, DeepIntent, ZS Associates, Indegene and Intouch Group / VMLY&R Health.

Does PharmaForceIQ have an API?

No public API is recorded for PharmaForceIQ.

What industry is PharmaForceIQ in?

PharmaForceIQ's product category is Pharmaceutical Marketing Software. Its primary akta.pro industry code is HDAEANAC, Model Serving, Inference & Deployment Platforms (APIs, Edge/On-Prem). Its NAICS code is 5132 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
AktienPharmaForceIQ Launches Share of Answer Module to Evaluate and Act on AI VisibilityPharmaForceIQ launched Share of Answer, a module in its Optichannel 360 platform, to evaluate and improve how therapies are represented in AI-generated answers. Audits showed brand websites accounted for only 17% of citations, and the module's controlled test raised answer accuracy to 94–100%.PR NewswirePharmaForceIQ Launches Share of Answer Module to Evaluate and Act on AI VisibilityPharmaForceIQ launched Share of Answer, a module in its Optichannel 360 platform, to evaluate and improve how therapies are represented in AI-generated answers. Audits showed brand and condition websites accounted for only 17% of AI-answer citations on average, and the module has analyzed over 10,000 responses.Third NewsPharmaForceIQ's Optichannel 360 Triumphs at PM360 Innovation Awards 2026PharmaForceIQ's Optichannel 360 won the PM360 Innovation Awards 2026 in the Marketing Technology or Services category. The AI-native platform unifies brand marketing and sales execution, processing over 100 million live preference signals across 75,000 endpoints. Its 2026 launch introduced packaged agentic AI for pharma commercial teams.PR NewswirePharmaForceIQ Wins in PM360 Innovation AwardsPharmaForceIQ's Optichannel 360 platform won a PM360 Innovation Award 2026 in the Marketing Technology or Services Category. The AI-native platform coordinates pharmaceutical brand marketing and sales execution, deployed across over 100 brands. The company plans to bring hundreds more life sciences teams onto its answer-to-action platform.PR NewswirePharmaForceIQ Wins in PM360 Innovation AwardsPharmaForceIQ's Optichannel 360 platform won a PM360 Innovation Award 2026 in the Marketing Technology or Services Category. The AI-native platform unifies pharmaceutical brand marketing and sales execution, deployed across over 100 brands. The company plans to bring hundreds more life sciences teams onto its answer-to-action platform.Third NewsPharmaForceIQ Unveils Optichannel 360: A Game-Changer for Pharma Marketing TeamsPharmaForceIQ announced the launch of Optichannel 360, an AI-native commercial execution platform designed to unify digital and field marketing across strategy, workflows, measurement and decision-making. The platform draws on over 200 million data points and offers a closed-loop answer-to-action workflow with NPI-level traceability. CEO Hemal Somaiya said rollout will begin with existing clients.PR NewswirePharmaForceIQ Launches Optichannel 360, the First AI-Native Answer-to-Action Engine for Pharma Commercial TeamsPharmaForceIQ announced on Aug. 26, 2026 the launch of Optichannel 360, an AI-native commercial execution platform for pharma teams that unifies field and digital marketing, strategy, systems, workflows, measurement, decisioning and execution. The first packaged capability is a measurement answer-to-action workflow grounded in over 200 million industry-contextual data points, routing approved next steps back into execution. Rollout begins with existing clients.PR NewswirePharmaForceIQ Launches Optichannel 360, the First AI-Native Answer-to-Action Engine for Pharma Commercial TeamsPharmaForceIQ launched Optichannel 360, an AI-native commercial execution platform for pharma teams, on Aug. 26, 2026. The platform connects field and digital marketing with a measurement answer-to-action workflow, grounded in over 200 million industry-contextual data points. It aims to turn measurement into a real-time learning loop across channels.BioPharma DivePharma marketers need a share-of-answer strategy before AI spendPharmaForceIQ's Stephen Onikoro told a sponsor interview that pharma marketers must shift from share-of-voice to share-of-answer as 81% of U.S. physicians report using AI tools in clinical practice. He cited 65% of physicians using OpenEvidence in April 2026 and 54% using generative AI for scientific information. Onikoro said marketers need audience affinity data and agent plug-ins to guide AI ad spend.pharmaphorumHarnessing AI to transform end-to-end customer engagement for pharma and biotechThis article discusses how AI can transform customer engagement in pharmaceutical and biotech marketing, highlighting that while 60% of pharma leaders report 2x ROI from AI initiatives within a year, less than 5% consider their organizations fully mature in AI adoption. The piece contrasts traditional omnichannel approaches (which eight in 10 executives say had little to no impact) with optichannel strategies that leverage AI to deliver personalized HCP journeys, claiming 3x average script lift and 20-30% budget savings. Authored by Derek Choy, head of product at PharmaForceIQ, the article promotes AI-powered marketing platforms as the solution to unify brand and field operations in pharma commercialization.